Roskoski, R., Jr. (2015). A historical overview of protein kinases and their targeted small molecule inhibitors. Pharmacological Research, 100, 1–23.

Article  PubMed  CAS  Google Scholar 

Roskoski, R., Jr. (2024). Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update. Pharmacological Research, 200, Article 107059.

Article  PubMed  CAS  Google Scholar 

Sigismund, S., Avanzato, D., & Lanzetti, L. (2018). Emerging functions of the EGFR in cancer. Molecular Oncology, 12, 3–20.

Article  PubMed  Google Scholar 

Poulikakos, P. I., Sullivan, R. J., & Yaeger, R. (2022). Molecular pathways and mechanisms of BRAF in cancer therapy. Clinical Cancer Research, 28, 4618–4628.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hoxhaj, G., & Manning, B. D. (2020). The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nature Reviews. Cancer, 20, 74–88.

Article  PubMed  CAS  Google Scholar 

Yoshida, S., & Yoshida, K. (2019). Multiple functions of DYRK2 in cancer and tissue development. FEBS Letters, 593, 2953–2965.

Article  PubMed  CAS  Google Scholar 

Nihira, N. T., & Yoshida, K. (2015). Engagement of DYRK2 in proper control for cell division. Cell Cycle (Georgetown, Tex.), 14, 802–807.

Article  PubMed  CAS  Google Scholar 

Tandon, V., de la Vega, L., & Banerjee, S. (2021). Emerging roles of DYRK2 in cancer. The Journal of biological chemistry, 296, 100233.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kawamura, A., Yoshida, S., & Yoshida, K. (2024). The diverse functions of DYRK2 in response to cellular stress. Histology and Histopathology, 39, 1427–1434.

PubMed  CAS  Google Scholar 

Taira, N., Mimoto, R., Kurata, M., Yamaguchi, T., Kitagawa, M., Miki, Y., et al. (2012). DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells. The Journal of Clinical Investigation, 122, 859–872.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mimoto, R., Taira, N., Takahashi, H., Yamaguchi, T., Okabe, M., Uchida, K., et al. (2013). DYRK2 controls the epithelial-mesenchymal transition in breast cancer by degrading Snail. Cancer Letters, 339, 214–225.

Article  PubMed  CAS  Google Scholar 

Ryu, K.-J., Park, S.-M., Park, S.-H., Kim, I.-K., Han, H.-T., Kim, H.-J., et al. (2019). p38 stabilizes snail by suppressing DYRK2-mediated phosphorylation that is required for GSK3β-βTrCP-induced snail degradation. Cancer Research, 79, 4135–4148.

Aranda, S., Laguna, A., & de la Luna, S. (2011). DYRK family of protein kinases: Evolutionary relationships, biochemical properties, and functional roles. The FASEB Journal, 25, 449–462.

Article  PubMed  CAS  Google Scholar 

Becker, W., & Joost, H. G. (1999). Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity. Progress in Nucleic Acid Research and Molecular Biology, 62, 1–17.

PubMed  CAS  Google Scholar 

Boni, J., Rubio-Perez, C., Lopez-Bigas, N., Fillat, C., & de la Luna, S. (2020). The DYRK family of kinases in cancer: Molecular functions and therapeutic opportunities. Cancers (Basel). https://doi.org/10.3390/cancers12082106

Article  PubMed  Google Scholar 

Chowdhury, I., Dashi, G., & Keskitalo, S. (2023). CMGC kinases in health and cancer. Cancers (Basel). https://doi.org/10.3390/cancers15153838

Article  PubMed  PubMed Central  Google Scholar 

Soppa, U., & Becker, W. (2015). DYRK protein kinases. Current Biology, 25, R488-489.

Article  PubMed  CAS  Google Scholar 

Becker, W., Weber, Y., Wetzel, K., Eirmbter, K., Tejedor, F. J., & Joost, H. G. (1998). Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases. The Journal of Biological Chemistry, 273, 25893–25902.

Article  PubMed  CAS  Google Scholar 

Correa-Saez, A., Jimenez-Izquierdo, R., Garrido-Rodriguez, M., Morrugares, R., Munoz, E., & Calzado, M. A. (2020). Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): Molecular basis, functions and role in diseases. Cellular and Molecular Life Sciences, 77, 4747–4763.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kinstrie, R., Luebbering, N., Miranda-Saavedra, D., Sibbet, G., Han, J., Lochhead, P. A., et al. (2010). Characterization of a domain that transiently converts class 2 DYRKs into intramolecular tyrosine kinases. Science Signaling, 3, ra16.

Article  PubMed  Google Scholar 

Taira, N., Yamamoto, H., Yamaguchi, T., Miki, Y., & Yoshida, K. (2010). ATM augments nuclear stabilization of DYRK2 by inhibiting MDM2 in the apoptotic response to DNA damage. The Journal of Biological Chemistry, 285, 4909–4919.

Article  PubMed  CAS  Google Scholar 

Xu, L., Sun, Y., Li, M., & Ge, X. (2018). Dyrk2 mediated the release of proinflammatory cytokines in LPS-induced BV2 cells. International Journal of Biological Macromolecules, 109, 1115–1124.

Article  PubMed  CAS  Google Scholar 

Rai, A. K., Chen, J. X., Selbach, M., & Pelkmans, L. (2018). Kinase-controlled phase transition of membraneless organelles in mitosis. Nature, 559, 211–216.

Article  PubMed  CAS  Google Scholar 

Soundararajan, M., Roos, A. K., Savitsky, P., Filippakopoulos, P., Kettenbach, A. N., Olsen, J. V., et al. (2013). Structures of Down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition. Structure, 21, 986–996.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lochhead, P. A., Sibbet, G., Morrice, N., & Cleghon, V. (2005). Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs. Cell, 121, 925–936.

Article  PubMed  CAS  Google Scholar 

Campbell, L. E., & Proud, C. G. (2002). Differing substrate specificities of members of the DYRK family of arginine-directed protein kinases. FEBS Letters, 510, 31–36.

Article  PubMed  CAS  Google Scholar 

Guo, X., Wang, X., Wang, Z., Banerjee, S., Yang, J., Huang, L., et al. (2016). Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis. Nature Cell Biology, 18, 202–212.

Article  PubMed  CAS  Google Scholar 

Moreno, R., Banerjee, S., Jackson, A. W., Quinn, J., Baillie, G., Dixon, J. E., et al. (2021). The stress-responsive kinase DYRK2 activates heat shock factor 1 promoting resistance to proteotoxic stress. Cell Death and Differentiation, 28, 1563–1578.

Article  PubMed  CAS  Google Scholar 

Taira, N., Nihira, K., Yamaguchi, T., Miki, Y., & Yoshida, K. (2007). DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage. Molecular Cell, 25, 725–738.

Article  PubMed  CAS  Google Scholar 

Perez, M., Garcia-Limones, C., Zapico, I., Marina, A., Schmitz, M. L., Munoz, E., et al. (2012). Mutual regulation between SIAH2 and DYRK2 controls hypoxic and genotoxic signaling pathways. Journal of Molecular Cell Biology, 4, 316–330.

Article  PubMed  CAS  Google Scholar 

Auld, G. C., Campbell, D. G., Morrice, N., & Cohen, P. (2005). Identification of calcium-regulated heat-stable protein of 24 kDa (CRHSP24) as a physiological substrate for PKB and RSK using KESTREL. Biochemical Journal, 389, 775–783.

Article  PubMed  PubMed Central  CAS